Using mouse models of liver cancer induced by tissue-specific overexpression of MYC [130] and MET [131], the effect of these two oncogenes on metabolic alterations in developed HCC were investigated by Yuneva and collaborators [120]. The gene discussed is MET; the disease is liver cancer.